Stella Chemifa (4109) AI Stock Analysis

• Market Cap: $47.21B
• Dividend Yield: 5.19%
• Average Volume (3M): 31.10K
• Price to Earnings (P/E): 15.8
• Beta (1Y): 0.75
• Revenue Growth: 11.06%
• EPS Growth: 23.01%
• Country: JP
• Employees: 695
• Sector: Industrials
• Sector Strength: 82
• Industry: Chemicals - Specialty
• EPS (TTM): 13.74
• Shares Outstanding: 12,973,248
• 10 Day Avg. Volume: 21,330
• 30 Day Avg. Volume: 31,100
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): 0.00
• Price to Cash Flow (P/CF): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

Stella Chemifa's strong profitability and balance sheet stability are offset by the concerning lack of cash flow data, impacting liquidity prospects. The technical analysis indicates a bearish trend, adding to short-term uncertainties. However, the stock's reasonable valuation and attractive dividend yield provide a cushion for investors seeking long-term returns.

Stella Chemifa Business Overview & Revenue Model

Company Description

Stella Chemifa Co., Ltd. is a Japan-based company primarily engaged in the manufacture and sale of chemical products. The company specializes in the production of high-purity chemicals, including fluorine compounds, silicon-based products, and other specialty chemicals. Stella Chemifa serves a diverse range of industries, including electronics, pharmaceuticals, and industrial manufacturing, by providing essential materials that support the development and production of advanced technologies.

How the Company Makes Money

Stella Chemifa generates revenue through the sale of its high-purity chemical products. The company's primary revenue streams include the sale of fluorine compounds, which are essential in various applications such as semiconductors, liquid crystal displays, and other electronic components. Additionally, the company produces and sells silicon-based products used in various industrial and pharmaceutical applications. Stella Chemifa's earnings are bolstered by its strategic partnerships and collaborations with major players in the electronics and pharmaceutical sectors, enabling it to maintain a strong market position and meet the growing demand for high-purity chemicals.

Stella Chemifa Financial Statement Overview

Summary

Income Statement

Balance Sheet

Cash Flow

Breakdown
Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Income Statement		Total Revenue
30.45B	35.38B	37.30B	32.89B	33.73B
	Gross Profit
6.45B	7.41B	8.90B	8.21B	6.68B
	EBIT
2.72B	3.51B	4.58B	4.08B	2.41B
	EBITDA
5.41B	6.11B	7.29B	7.11B	5.64B
	Net Income Common Stockholders
1.84B	2.28B	5.36B	2.96B	1.92B
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
16.23B	15.10B	15.89B	15.57B	13.59B
	Total Assets
58.62B	55.47B	56.60B	52.93B	53.22B
	Total Debt
4.93B	3.92B	5.42B	8.71B	11.71B
	Net Debt
-11.30B	-11.18B	-10.48B	-6.85B	-1.88B
	Total Liabilities
14.12B	12.31B	13.87B	16.18B	18.49B
	Stockholders Equity
44.26B	42.92B	42.22B	36.27B	34.06B
Cash Flow		Free Cash Flow
683.00M	1.05B	2.68B	4.92B	388.00M
	Operating Cash Flow
6.54B	5.63B	5.40B	7.35B	5.04B
	Investing Cash Flow
-5.83B	-3.28B	-5.67B	-2.46B	-3.17B
	Financing Cash Flow
-141.00M	-3.72B	94.00M	-3.00B	-715.00M

Stella Chemifa Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 3620.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4109, the sentiment is Negative. The current price of 3620 is below the 20-day moving average (MA) of 3626.75, below the 50-day MA of 3820.62, and below the 200-day MA of 4001.72, indicating a bearish trend. The MACD of -15.15 indicates Negative momentum. The RSI at 43.83 is Neutral, neither overbought nor oversold. The STOCH value of 55.96 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4109.

Stella Chemifa Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
4043	75 Outperform	$202.29B	8.65	9.01%	3.41%	0.32%	31.76%
4021	71 Outperform	€576.35B	13.35	19.18%	3.87%	9.83%	22.31%
4045	71 Outperform	$150.81B	13.68	5.27%	4.14%	5.13%	-8.77%
4109	68 Neutral	$47.21B	15.76	6.26%	5.19%	11.06%	23.01%
4046	66 Neutral	¥193.44B	18.31		1.25%	2.35%	86.60%
4114	66 Neutral	¥258.90B	16.80		6.47%	5.66%	77.87%
Sector *	61 Neutral	$703.90M	7.16	6.37%	3.65%	1.48%	-24.42%

Stella Chemifa Corporate Events

Stella Chemifa Announces Change in Largest Shareholder

Stella Chemifa Corporation announced a change in its largest shareholder, with Dalton Investments, Inc. now holding the largest share as of April 3, 2025. This shift in shareholder structure may influence the company’s strategic direction and impact its market positioning, as Dalton Investments increases its stake from 14.89% to 15.82%.

Stella Chemifa Reports Strong Financial Growth for 2024

Stella Chemifa Corporation reported a significant financial improvement for the nine months ending December 31, 2024, with a 14.3% increase in sales revenue to ¥26,652 million and a notable rise in profit attributable to owners of the parent by 60.3% year-over-year. These results reflect the company’s strong operational performance and strategic positioning in the market, potentially enhancing shareholder value and indicating robust growth prospects.